Abacavir does not influence the rate of sustained virological response in HIV-HCV co-infected patients treated with pegylated interferon and weight adjusted ribavirin

INTRODUCTION: Combination of pegylated-interferon (PEG-IFN) plus ribavirin (RBV) is the standard-of-care for hepatitis C virus (HCV) treatment in HIV coinfected individuals. In 2007, abacavir (ABC)-based antiretroviral therapy was for the first time reported to be associated with early virological f...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: N, Laufer, M, Laguno, I, Perez, C, Cifuentes, J, Murillas, F, Vidal, L, Bonet, S, Veloso, JM, Gatell, J, Mallolas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2883773/
https://ncbi.nlm.nih.gov/pubmed/19043930
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller